Patents Assigned to ARV Pharma Inc.
  • Avian oncolytic virus having modified sequences and uses thereof
    Patent number: 10829786
    Abstract: The present disclosure relates to one or more modified avian-virus based agents, therapies, treatments, and methods of use of the modified avian-virus based agents and/or therapies and/or treatments for cancer. The disclosure also provides for methods of generating modified avian-virus based agents.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: November 10, 2020
    Assignee: ARV Pharma Inc.
    Inventors: Robert Kozak, Byram Bridle, Eva Nagy, Bradley Thompson